These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495 [TBL] [Abstract][Full Text] [Related]
3. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317 [TBL] [Abstract][Full Text] [Related]
4. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review. Mahmoudi H; Hossainpour H Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458 [TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile. Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776 [TBL] [Abstract][Full Text] [Related]
6. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease. Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592 [TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989 [TBL] [Abstract][Full Text] [Related]
8. Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma. Sabus A; Merrow M; Heiden A; Boster J; Koo J; Franklin ARK J Pediatr Hematol Oncol; 2021 Aug; 43(6):e897-e899. PubMed ID: 33273413 [TBL] [Abstract][Full Text] [Related]
9. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721 [TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for treatment of patients with recurrent Voth E; Khanna S Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848 [TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients. Bernard R; Hourigan SK; Nicholson MR J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S58-S63. PubMed ID: 34791396 [TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation. Dawwas GK; Brensinger CM; Vajravelu RK; Wu Q; Kelly CR; Laine L; Wu GD; Lewis JD Clin Gastroenterol Hepatol; 2022 Apr; 20(4):806-816.e6. PubMed ID: 33307184 [TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience. Pipek B; Valentová H; Fojtík P; Urban O Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450 [TBL] [Abstract][Full Text] [Related]
16. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529 [TBL] [Abstract][Full Text] [Related]
17. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855 [TBL] [Abstract][Full Text] [Related]
18. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease. Patwa SA; Ward C; Kelly CR R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959 [TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases. Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530 [TBL] [Abstract][Full Text] [Related]
20. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Tian H; Cui J; Ye C; Zhao J; Yang B; Xu Y; Ji S; Wang L; Lv X; Ma C; Zhou S; Li N; Wang X; Qin H; Chen Q Gut Microbes; 2023; 15(1):2236362. PubMed ID: 37469017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]